Jiang XL, Liu BY, Nie Z, Duan LC, Xiong QX, Jin ZX, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi HL, Wei JB, He C. Where, when, and how: context-dependent functions of rna methylation writers, readers, and erasers. Mol Cell. 2019;74:640–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, et al. 5′ UTR m(6)A promotes Cap-independent translation. Cell. 2015;163:999–1010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao W, Adhikari S, Dahal U, Chen Y-S, Hao Y-J, Sun B-F, et al. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507–19.

Article  CAS  PubMed  Google Scholar 

Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer cell. 2020;37:270–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li A, Chen Y-S, Ping X-L, Yang X, Xiao W, Yang Y, et al. Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation. Cell Res. 2017;27:444–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;149:1635–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Feng J, Xue Y, Guan ZY, Zhang DL, Liu Z, et al. Structural basis of N6-adenosine methylation by the METTL3-METTL14 complex. Nature. 2017;542:260–260.

Article  CAS  PubMed  Google Scholar 

Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201–U284.

Article  CAS  PubMed  Google Scholar 

Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93–95.

Article  CAS  PubMed  Google Scholar 

Ping X-L, Sun B-F, Wang L, Xiao W, Yang X, Wang W-J, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue YA, Liu J, Cui XL, Cao J, Luo GZ, Zhang ZZ, et al. VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10.

Article  PubMed  PubMed Central  Google Scholar 

Knuckles P, Lence T, Haussmann IU, Jacob D, Kreim N, Carl SH, et al. Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d. Genes Dev. 2018;32:415–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bawankar P, Lence T, Paolantoni C, Haussmann IU, Kazlauskiene M, Jacob D, et al. Hakai is required for stabilization of core components of the m6A mRNA methylation machinery. Nat Commun. 2021;12:3778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang YJ, Yang B, Lai Q, Shi JF, Peng JY, Zhang Y, et al. Reprogramming of m6A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia. RNA Biol. 2021;18:131–43.

Article  CAS  PubMed  Google Scholar 

Liu C, Sun HX, Yi YP, Shen WG, Li K, Xiao Y, et al. Absolute quantification of single-base m6A methylation in the mammalian transcriptome using GLORI. Nat Biotechnol. 2023;41:355.

Article  CAS  PubMed  Google Scholar 

Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m(6)A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA. 2016;113:E2047–2056.

CAS  PubMed  PubMed Central  Google Scholar 

Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501.

Article  CAS  PubMed  Google Scholar 

Merlin JL, Lion M, Wong J, Bachelot T, André F, Treilleux I, et al. Quantitative analysis of tumor expression of phosphoproteins from PI3-kinase and MAP-kinase signaling pathways as biomarkers of the biological and clinical activity of trastuzumab and everolimus in breast cancer: Unicancer RADHER phase II trial results. Cancer Res. 2013;73(24 Suppl): Abstract nr P1-08-27.

Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3:11–22.

Article  CAS  PubMed  Google Scholar 

Zhang CZ, Samanta D, Lu HQ, Bullen JW, Zhang HM, Chen I, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA. 2016;113:E2047–E2056.

CAS  PubMed  PubMed Central  Google Scholar 

Liu XY, Feng MX, Hao XD, Gao ZH, Wu ZX, Wang YL, et al. m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop. Oncogene. 2023;42:2047–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu M, Flanagan JU, Langley RJ, Hay MP, Perry JK. Targeting growth hormone function: strategies and therapeutic applications. Signal Transduct Target Ther. 2019;4:3.

Article  PubMed  PubMed Central  Google Scholar 

Brown GD, Willment JA, Whitehead L. C-type lectins in immunity and homeostasis. Nat Rev Immunol. 2018;18:374–89.

Article  CAS  PubMed  Google Scholar 

Uribe ML, Marrocco I, Yarden Y. EGFR in cancer: signaling mechanisms, drugs, and acquired resistance. Cancers. 2021;13:2748.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv Z, Ding Y, Cao W, Wang S, Gao K. Role of RHO family interacting cell polarization regulators (RIPORs) in health and disease: recent advances and prospects. Int J Biol Sci. 2022;18:800–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan C, Xiong J, Zhou Z, Li Q, Gao C, Zhang M, et al. A cleaved METTL3 potentiates the METTL3-WTAP interaction and breast cancer progression. Elife. 2023;12:RP87283.

Article  CAS